Phase
Condition
Fibromyalgia
Treatment
Mecobalamin 5 MG
Placebo Comparator : NaCl 9 mg/ml
Clinical Study ID
Ages 18-70 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Women aged 20-70 years
Swedish-speaking
Diagnosis of fibromyalgia
Safe method of contraception
Cobalamin / p (vitamin B12) should be >250 pmol/L < 800 pmol/L
Given consent to participate.
Exclusion
Exclusion Criteria:
Previous treatment with B12
Known hypersensitivity to the active substance Mecobalamin or an additive
Vegan as veganism can lead to B12 deficiency
Neuroleptics
Known heart, kidney or liver disease
Reynaud's phenomenon (white fingers)
Known neuropathy (impaired sensation)
Breastfeeding
Pregnancy or plan pregnancy
Study Design
Connect with a study center
Linnaeus University
Växjö, Kronoberg 352 91
SwedenSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.